Targeting the Cytosolic Innate Immune Receptors RIG-I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in Glioblastoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Cytosolic Innate Immune Receptors RIG-I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in Glioblastoma
Authors
Keywords
-
Journal
STEM CELLS
Volume 31, Issue 6, Pages 1064-1074
Publisher
Wiley
Online
2013-02-07
DOI
10.1002/stem.1350
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Self-Renewal Does Not Predict Tumor Growth Potential in Mouse Models of High-Grade Glioma
- (2012) Lindy E. Barrett et al. CANCER CELL
- Capture of Neuroepithelial-Like Stem Cells from Pluripotent Stem Cells Provides a Versatile System for In Vitro Production of Human Neurons
- (2012) Anna Falk et al. PLoS One
- Current concepts and management of glioblastoma
- (2011) Matthias Preusser et al. ANNALS OF NEUROLOGY
- Heterogeneity Maintenance in Glioblastoma: A Social Network
- (2011) R. Bonavia et al. CANCER RESEARCH
- Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells
- (2011) Kirsten Kübler et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The neurobiology of gliomas: from cell biology to the development of therapeutic approaches
- (2011) Manfred Westphal et al. NATURE REVIEWS NEUROSCIENCE
- Targeted Activation of RNA Helicase Retinoic Acid-Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells
- (2010) K. Kubler et al. CANCER RESEARCH
- Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy
- (2010) D. Alizadeh et al. CLINICAL CANCER RESEARCH
- Immunotherapy coming of age: What will it take to make it standard of care for glioblastoma?
- (2010) A. B. Heimberger et al. NEURO-ONCOLOGY
- A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
- (2010) M. R. Rosenfeld et al. NEURO-ONCOLOGY
- Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells
- (2009) Damià Tormo et al. CANCER CELL
- Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
- (2009) Steven M. Pollard et al. Cell Stem Cell
- Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7
- (2009) Delphine Goubau et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Recognition of 5′ Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand Virus
- (2009) Martin Schlee et al. IMMUNITY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Immunostimulants for Malignant Gliomas
- (2009) Nicholas Butowski NEUROSURGERY CLINICS OF NORTH AMERICA
- A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration
- (2009) P. Koch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotherapy of malignant brain tumors
- (2008) Duane A. Mitchell et al. IMMUNOLOGICAL REVIEWS
- 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
- (2008) Hendrik Poeck et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation